Chuan (Joe) Shih, Ph.D.

Dr. Shih is currently a Venture Partner of Lilly Asia Ventures with over 30 years of experience working within the life sciences industry. Before joining Lilly Asia Ventures, he was the Director of the Institute of Biotechnology and Pharmaceutical Research (IBPR) of the National Health Research Institutes (NHRI), a premier new drug discovery institute in Taiwan. Prior to IBPR, Dr. Shih led drug discovery and translational medicine teams across multiple therapeutic areas at Crown Biosciences, Inc. Lilly Research Laboratories and Eli Lilly and Company. Over his career, Dr. Shih has led discovery efforts that have resulted in or contributed to multiple successful commercial products. He received numerous achievement awards throughout his career including the 2006 American Chemical Society “Heroes of Chemistry” Award for his role in the discovery and development of Alimta®.

Dr. Shih received his Ph.D. in organic chemistry from Ohio State University. He completed a postdoctoral fellowship at Harvard University under Nobel Laureate Professor E. J. Corey.